108 related articles for article (PubMed ID: 29428923)
1. Content Analysis of Commercially Available Probiotics.
Yadav P; Sharma P; Arora R
Indian Pediatr; 2018 Apr; 55(4):344-345. PubMed ID: 29428923
[TBL] [Abstract][Full Text] [Related]
2. Microbiological and molecular characterization of commercially available probiotics containing Bacillus clausii from India and Pakistan.
Patrone V; Molinari P; Morelli L
Int J Food Microbiol; 2016 Nov; 237():92-97. PubMed ID: 27543819
[TBL] [Abstract][Full Text] [Related]
3. Identification of Bacillus species: Implication on the quality of probiotic formulations.
Celandroni F; Vecchione A; Cara A; Mazzantini D; Lupetti A; Ghelardi E
PLoS One; 2019; 14(5):e0217021. PubMed ID: 31107885
[TBL] [Abstract][Full Text] [Related]
4. Bacteremia after Bacillus clausii administration for the treatment of acute diarrhea: A case report.
García JP; Hoyos JA; Alzate JA; Cristancho E
Biomedica; 2021 Oct; 41(Sp. 2):13-20. PubMed ID: 34669274
[TBL] [Abstract][Full Text] [Related]
5. Quantitative and qualitative characterization of commercially available oral suspension of probiotic products containing Bacillus Clausii spores.
Kharwar A; Bazaz MR; Dandekar MP
BMC Microbiol; 2022 Sep; 22(1):217. PubMed ID: 36114449
[TBL] [Abstract][Full Text] [Related]
6. Composite genome sequence of Bacillus clausii, a probiotic commercially available as Enterogermina
Khatri I; Sharma G; Subramanian S
BMC Microbiol; 2019 Dec; 19(1):307. PubMed ID: 31888501
[TBL] [Abstract][Full Text] [Related]
7. Strain-level diversity of commercial probiotic isolates of Bacillus, Lactobacillus, and Saccharomyces species illustrated by molecular identification and phenotypic profiling.
Ansari JM; Colasacco C; Emmanouil E; Kohlhepp S; Harriott O
PLoS One; 2019; 14(3):e0213841. PubMed ID: 30901338
[TBL] [Abstract][Full Text] [Related]
8. Establishment and application of an analytical in-house database (IHDB) for rapid discrimination of Bacillus subtilis group (BSG) using whole-cell MALDI-TOF MS technology.
Huang CH; Huang L; Chang MT; Chen KL
Mol Cell Probes; 2016 Oct; 30(5):312-319. PubMed ID: 27507023
[TBL] [Abstract][Full Text] [Related]
9. Capillary isoelectric focusing of probiotic bacteria from cow's milk in tapered fused silica capillary with off-line matrix-assisted laser desorption/ionization time-of-flight mass spectrometry identification.
Horká M; Karásek P; Salplachta J; Růžička F; Vykydalová M; Kubesová A; Dráb V; Roth M; Slais K
Anal Chim Acta; 2013 Jul; 788():193-9. PubMed ID: 23845500
[TBL] [Abstract][Full Text] [Related]
10. Bacillus subtilis subsp. subtilis CBMDC3f with antimicrobial activity against Gram-positive foodborne pathogenic bacteria: UV-MALDI-TOF MS analysis of its bioactive compounds.
Torres MJ; Petroselli G; Daz M; Erra-Balsells R; Audisio MC
World J Microbiol Biotechnol; 2015 Jun; 31(6):929-40. PubMed ID: 25820813
[TBL] [Abstract][Full Text] [Related]
11. Secreted Compounds of the Probiotic Bacillus clausii Strain O/C Inhibit the Cytotoxic Effects Induced by Clostridium difficile and Bacillus cereus Toxins.
Ripert G; Racedo SM; Elie AM; Jacquot C; Bressollier P; Urdaci MC
Antimicrob Agents Chemother; 2016 Jun; 60(6):3445-54. PubMed ID: 27001810
[TBL] [Abstract][Full Text] [Related]
12. Characterisation and profiling of Bacillus subtilis, Bacillus cereus and Bacillus licheniformis by MALDI-TOF mass fingerprinting.
Fernández-No IC; Böhme K; Díaz-Bao M; Cepeda A; Barros-Velázquez J; Calo-Mata P
Food Microbiol; 2013 Apr; 33(2):235-42. PubMed ID: 23200657
[TBL] [Abstract][Full Text] [Related]
13. Protective action of Bacillus clausii probiotic strains in an in vitro model of Rotavirus infection.
Paparo L; Tripodi L; Bruno C; Pisapia L; Damiano C; Pastore L; Berni Canani R
Sci Rep; 2020 Jul; 10(1):12636. PubMed ID: 32724066
[TBL] [Abstract][Full Text] [Related]
14. Survival and persistence of Bacillus clausii in the human gastrointestinal tract following oral administration as spore-based probiotic formulation.
Ghelardi E; Celandroni F; Salvetti S; Gueye SA; Lupetti A; Senesi S
J Appl Microbiol; 2015 Aug; 119(2):552-9. PubMed ID: 25973914
[TBL] [Abstract][Full Text] [Related]
15. Characterization of microorganisms by MALDI mass spectrometry.
Petersen CE; Valentine NB; Wahl KL
Methods Mol Biol; 2009; 492():367-79. PubMed ID: 19241045
[TBL] [Abstract][Full Text] [Related]
16. Bio-removal of tetracycline antibiotics under the consortium with probiotics Bacillus clausii T and Bacillus amyloliquefaciens producing biosurfactants.
Liu CX; Xu QM; Yu SC; Cheng JS; Yuan YJ
Sci Total Environ; 2020 Mar; 710():136329. PubMed ID: 31918182
[TBL] [Abstract][Full Text] [Related]
17. Bacillus clausii for Gastrointestinal Disorders: A Narrative Literature Review.
Acosta-Rodríguez-Bueno CP; Abreu Y Abreu AT; Guarner F; Guno MJV; Pehlivanoğlu E; Perez M
Adv Ther; 2022 Nov; 39(11):4854-4874. PubMed ID: 36018495
[TBL] [Abstract][Full Text] [Related]
18. Effect of culture conditions on microorganism identification by matrix-assisted laser desorption ionization mass spectrometry.
Valentine N; Wunschel S; Wunschel D; Petersen C; Wahl K
Appl Environ Microbiol; 2005 Jan; 71(1):58-64. PubMed ID: 15640170
[TBL] [Abstract][Full Text] [Related]
19. Species identification of clinical isolates of Bacteroides by matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry.
Nagy E; Maier T; Urban E; Terhes G; Kostrzewa M;
Clin Microbiol Infect; 2009 Aug; 15(8):796-802. PubMed ID: 19438622
[TBL] [Abstract][Full Text] [Related]
20. Negative and positive ion matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and positive ion nano-electrospray ionization quadrupole ion trap mass spectrometry of peptidoglycan fragments isolated from various Bacillus species.
Bacher G; Körner R; Atrih A; Foster SJ; Roepstorff P; Allmaier G
J Mass Spectrom; 2001 Feb; 36(2):124-39. PubMed ID: 11288194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
